Supplementary Table S2 from PET/CT Biomarkers Enable Risk Stratification of Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma Enrolled in the LOTIS-2 Clinical Trial Article Swipe
Juan Pablo Alderuccio
,
Isildinha M. Reis
,
Mehdi Hamadani
,
Muthiah Nachiappan
,
Salman Leslom
,
Brad S. Kahl
,
Weiyun Z. Ai
,
John Radford
,
Melhem Solh
,
Kirit M. Ardeshna
,
Brian T. Hess
,
Matthew A. Lunning
,
Pier Luigi Zinzani
,
Anastasios Stathis
,
Carmelo Carlo‐Stella
,
Izidore S. Lossos
,
Paolo F. Caimi
,
Sunwoo Han
,
Fei Yang
,
Russ Kuker
,
Craig H. Moskowitz
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1158/1078-0432.24947779
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1158/1078-0432.24947779
Study representativeness table.
Related Topics
Concepts
Metadata
- Type
- supplementary-materials
- Language
- en
- Landing Page
- https://doi.org/10.1158/1078-0432.24947779
- OA Status
- gold
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4390613631
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4390613631Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1158/1078-0432.24947779Digital Object Identifier
- Title
-
Supplementary Table S2 from PET/CT Biomarkers Enable Risk Stratification of Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma Enrolled in the LOTIS-2 Clinical TrialWork title
- Type
-
supplementary-materialsOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-01-05Full publication date if available
- Authors
-
Juan Pablo Alderuccio, Isildinha M. Reis, Mehdi Hamadani, Muthiah Nachiappan, Salman Leslom, Brad S. Kahl, Weiyun Z. Ai, John Radford, Melhem Solh, Kirit M. Ardeshna, Brian T. Hess, Matthew A. Lunning, Pier Luigi Zinzani, Anastasios Stathis, Carmelo Carlo‐Stella, Izidore S. Lossos, Paolo F. Caimi, Sunwoo Han, Fei Yang, Russ Kuker, Craig H. MoskowitzList of authors in order
- Landing page
-
https://doi.org/10.1158/1078-0432.24947779Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1158/1078-0432.24947779Direct OA link when available
- Concepts
-
Risk stratification, Medicine, Diffuse large B-cell lymphoma, Lymphoma, Clinical trial, Refractory (planetary science), Oncology, Stratification (seeds), Internal medicine, Radiology, Nuclear medicine, Materials science, Germination, Seed dormancy, Botany, Dormancy, Composite material, BiologyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4390613631 |
|---|---|
| doi | https://doi.org/10.1158/1078-0432.24947779 |
| ids.doi | https://doi.org/10.1158/1078-0432.24947779 |
| ids.openalex | https://openalex.org/W4390613631 |
| fwci | |
| type | supplementary-materials |
| title | Supplementary Table S2 from PET/CT Biomarkers Enable Risk Stratification of Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma Enrolled in the LOTIS-2 Clinical Trial |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T10185 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9948999881744385 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2734 |
| topics[0].subfield.display_name | Pathology and Forensic Medicine |
| topics[0].display_name | Lymphoma Diagnosis and Treatment |
| topics[1].id | https://openalex.org/T10522 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9639000296592712 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2741 |
| topics[1].subfield.display_name | Radiology, Nuclear Medicine and Imaging |
| topics[1].display_name | Medical Imaging Techniques and Applications |
| topics[2].id | https://openalex.org/T10417 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9544000029563904 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2740 |
| topics[2].subfield.display_name | Pulmonary and Respiratory Medicine |
| topics[2].display_name | Lung Cancer Treatments and Mutations |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C3020404979 |
| concepts[0].level | 2 |
| concepts[0].score | 0.769690215587616 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q1058438 |
| concepts[0].display_name | Risk stratification |
| concepts[1].id | https://openalex.org/C71924100 |
| concepts[1].level | 0 |
| concepts[1].score | 0.730679988861084 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[1].display_name | Medicine |
| concepts[2].id | https://openalex.org/C2778559949 |
| concepts[2].level | 3 |
| concepts[2].score | 0.7288216352462769 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q2626074 |
| concepts[2].display_name | Diffuse large B-cell lymphoma |
| concepts[3].id | https://openalex.org/C2779338263 |
| concepts[3].level | 2 |
| concepts[3].score | 0.5620527863502502 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q208414 |
| concepts[3].display_name | Lymphoma |
| concepts[4].id | https://openalex.org/C535046627 |
| concepts[4].level | 2 |
| concepts[4].score | 0.5546090006828308 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q30612 |
| concepts[4].display_name | Clinical trial |
| concepts[5].id | https://openalex.org/C142424586 |
| concepts[5].level | 2 |
| concepts[5].score | 0.5340332984924316 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q7307572 |
| concepts[5].display_name | Refractory (planetary science) |
| concepts[6].id | https://openalex.org/C143998085 |
| concepts[6].level | 1 |
| concepts[6].score | 0.46201860904693604 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[6].display_name | Oncology |
| concepts[7].id | https://openalex.org/C192943249 |
| concepts[7].level | 5 |
| concepts[7].score | 0.42233407497406006 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q1893382 |
| concepts[7].display_name | Stratification (seeds) |
| concepts[8].id | https://openalex.org/C126322002 |
| concepts[8].level | 1 |
| concepts[8].score | 0.4112371802330017 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[8].display_name | Internal medicine |
| concepts[9].id | https://openalex.org/C126838900 |
| concepts[9].level | 1 |
| concepts[9].score | 0.343464732170105 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q77604 |
| concepts[9].display_name | Radiology |
| concepts[10].id | https://openalex.org/C2989005 |
| concepts[10].level | 1 |
| concepts[10].score | 0.32140135765075684 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q214963 |
| concepts[10].display_name | Nuclear medicine |
| concepts[11].id | https://openalex.org/C192562407 |
| concepts[11].level | 0 |
| concepts[11].score | 0.06419658660888672 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q228736 |
| concepts[11].display_name | Materials science |
| concepts[12].id | https://openalex.org/C100701293 |
| concepts[12].level | 2 |
| concepts[12].score | 0.0 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q193838 |
| concepts[12].display_name | Germination |
| concepts[13].id | https://openalex.org/C88548481 |
| concepts[13].level | 4 |
| concepts[13].score | 0.0 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q2397491 |
| concepts[13].display_name | Seed dormancy |
| concepts[14].id | https://openalex.org/C59822182 |
| concepts[14].level | 1 |
| concepts[14].score | 0.0 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q441 |
| concepts[14].display_name | Botany |
| concepts[15].id | https://openalex.org/C3527866 |
| concepts[15].level | 3 |
| concepts[15].score | 0.0 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q162267 |
| concepts[15].display_name | Dormancy |
| concepts[16].id | https://openalex.org/C159985019 |
| concepts[16].level | 1 |
| concepts[16].score | 0.0 |
| concepts[16].wikidata | https://www.wikidata.org/wiki/Q181790 |
| concepts[16].display_name | Composite material |
| concepts[17].id | https://openalex.org/C86803240 |
| concepts[17].level | 0 |
| concepts[17].score | 0.0 |
| concepts[17].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[17].display_name | Biology |
| keywords[0].id | https://openalex.org/keywords/risk-stratification |
| keywords[0].score | 0.769690215587616 |
| keywords[0].display_name | Risk stratification |
| keywords[1].id | https://openalex.org/keywords/medicine |
| keywords[1].score | 0.730679988861084 |
| keywords[1].display_name | Medicine |
| keywords[2].id | https://openalex.org/keywords/diffuse-large-b-cell-lymphoma |
| keywords[2].score | 0.7288216352462769 |
| keywords[2].display_name | Diffuse large B-cell lymphoma |
| keywords[3].id | https://openalex.org/keywords/lymphoma |
| keywords[3].score | 0.5620527863502502 |
| keywords[3].display_name | Lymphoma |
| keywords[4].id | https://openalex.org/keywords/clinical-trial |
| keywords[4].score | 0.5546090006828308 |
| keywords[4].display_name | Clinical trial |
| keywords[5].id | https://openalex.org/keywords/refractory |
| keywords[5].score | 0.5340332984924316 |
| keywords[5].display_name | Refractory (planetary science) |
| keywords[6].id | https://openalex.org/keywords/oncology |
| keywords[6].score | 0.46201860904693604 |
| keywords[6].display_name | Oncology |
| keywords[7].id | https://openalex.org/keywords/stratification |
| keywords[7].score | 0.42233407497406006 |
| keywords[7].display_name | Stratification (seeds) |
| keywords[8].id | https://openalex.org/keywords/internal-medicine |
| keywords[8].score | 0.4112371802330017 |
| keywords[8].display_name | Internal medicine |
| keywords[9].id | https://openalex.org/keywords/radiology |
| keywords[9].score | 0.343464732170105 |
| keywords[9].display_name | Radiology |
| keywords[10].id | https://openalex.org/keywords/nuclear-medicine |
| keywords[10].score | 0.32140135765075684 |
| keywords[10].display_name | Nuclear medicine |
| keywords[11].id | https://openalex.org/keywords/materials-science |
| keywords[11].score | 0.06419658660888672 |
| keywords[11].display_name | Materials science |
| language | en |
| locations[0].id | doi:10.1158/1078-0432.24947779 |
| locations[0].is_oa | True |
| locations[0].source | |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | acceptedVersion |
| locations[0].raw_type | posted-content |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | False |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.1158/1078-0432.24947779 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5079899240 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-2690-3377 |
| authorships[0].author.display_name | Juan Pablo Alderuccio |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Juan Pablo Alderuccio |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5062422300 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-7695-8771 |
| authorships[1].author.display_name | Isildinha M. Reis |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Isildinha M. Reis |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5011030256 |
| authorships[2].author.orcid | https://orcid.org/0000-0001-5372-510X |
| authorships[2].author.display_name | Mehdi Hamadani |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Mehdi Hamadani |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5002372929 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Muthiah Nachiappan |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Muthiah Nachiappan |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5093090328 |
| authorships[4].author.orcid | https://orcid.org/0009-0007-6210-4322 |
| authorships[4].author.display_name | Salman Leslom |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Salman Leslom |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5069054551 |
| authorships[5].author.orcid | https://orcid.org/0000-0003-0459-6609 |
| authorships[5].author.display_name | Brad S. Kahl |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Brad S. Kahl |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5050290286 |
| authorships[6].author.orcid | https://orcid.org/0000-0001-5757-6949 |
| authorships[6].author.display_name | Weiyun Z. Ai |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Weiyun Z. Ai |
| authorships[6].is_corresponding | False |
| authorships[7].author.id | https://openalex.org/A5011398209 |
| authorships[7].author.orcid | https://orcid.org/0000-0001-7898-2786 |
| authorships[7].author.display_name | John Radford |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | John Radford |
| authorships[7].is_corresponding | False |
| authorships[8].author.id | https://openalex.org/A5004066032 |
| authorships[8].author.orcid | https://orcid.org/0000-0003-3766-5623 |
| authorships[8].author.display_name | Melhem Solh |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Melhem Solh |
| authorships[8].is_corresponding | False |
| authorships[9].author.id | https://openalex.org/A5053161231 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-8938-7875 |
| authorships[9].author.display_name | Kirit M. Ardeshna |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Kirit M. Ardeshna |
| authorships[9].is_corresponding | False |
| authorships[10].author.id | https://openalex.org/A5035541800 |
| authorships[10].author.orcid | https://orcid.org/0000-0003-0176-2050 |
| authorships[10].author.display_name | Brian T. Hess |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Brian T. Hess |
| authorships[10].is_corresponding | False |
| authorships[11].author.id | https://openalex.org/A5088179815 |
| authorships[11].author.orcid | https://orcid.org/0000-0002-2761-7612 |
| authorships[11].author.display_name | Matthew A. Lunning |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Matthew A. Lunning |
| authorships[11].is_corresponding | False |
| authorships[12].author.id | https://openalex.org/A5091882595 |
| authorships[12].author.orcid | https://orcid.org/0000-0002-2112-2651 |
| authorships[12].author.display_name | Pier Luigi Zinzani |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Pier Luigi Zinzani |
| authorships[12].is_corresponding | False |
| authorships[13].author.id | https://openalex.org/A5048622832 |
| authorships[13].author.orcid | https://orcid.org/0000-0002-2859-7529 |
| authorships[13].author.display_name | Anastasios Stathis |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Anastasios Stathis |
| authorships[13].is_corresponding | False |
| authorships[14].author.id | https://openalex.org/A5042459008 |
| authorships[14].author.orcid | https://orcid.org/0000-0003-3144-0124 |
| authorships[14].author.display_name | Carmelo Carlo‐Stella |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Carmelo Carlo-Stella |
| authorships[14].is_corresponding | False |
| authorships[15].author.id | https://openalex.org/A5049069261 |
| authorships[15].author.orcid | https://orcid.org/0000-0002-9346-9013 |
| authorships[15].author.display_name | Izidore S. Lossos |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Izidore S. Lossos |
| authorships[15].is_corresponding | False |
| authorships[16].author.id | https://openalex.org/A5016048836 |
| authorships[16].author.orcid | https://orcid.org/0000-0003-1436-0464 |
| authorships[16].author.display_name | Paolo F. Caimi |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | Paolo F. Caimi |
| authorships[16].is_corresponding | False |
| authorships[17].author.id | https://openalex.org/A5024332631 |
| authorships[17].author.orcid | https://orcid.org/0000-0001-6874-2471 |
| authorships[17].author.display_name | Sunwoo Han |
| authorships[17].author_position | middle |
| authorships[17].raw_author_name | Sunwoo Han |
| authorships[17].is_corresponding | False |
| authorships[18].author.id | https://openalex.org/A5042539760 |
| authorships[18].author.orcid | https://orcid.org/0000-0001-6260-9020 |
| authorships[18].author.display_name | Fei Yang |
| authorships[18].author_position | middle |
| authorships[18].raw_author_name | Fei Yang |
| authorships[18].is_corresponding | False |
| authorships[19].author.id | https://openalex.org/A5052539381 |
| authorships[19].author.orcid | https://orcid.org/0000-0002-0074-6596 |
| authorships[19].author.display_name | Russ Kuker |
| authorships[19].author_position | middle |
| authorships[19].raw_author_name | Russ A. Kuker |
| authorships[19].is_corresponding | False |
| authorships[20].author.id | https://openalex.org/A5001102192 |
| authorships[20].author.orcid | https://orcid.org/0000-0002-9189-3152 |
| authorships[20].author.display_name | Craig H. Moskowitz |
| authorships[20].author_position | last |
| authorships[20].raw_author_name | Craig H. Moskowitz |
| authorships[20].is_corresponding | False |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1158/1078-0432.24947779 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Supplementary Table S2 from PET/CT Biomarkers Enable Risk Stratification of Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma Enrolled in the LOTIS-2 Clinical Trial |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10185 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9948999881744385 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2734 |
| primary_topic.subfield.display_name | Pathology and Forensic Medicine |
| primary_topic.display_name | Lymphoma Diagnosis and Treatment |
| related_works | https://openalex.org/W4386554877, https://openalex.org/W3173424037, https://openalex.org/W4236138976, https://openalex.org/W3203136021, https://openalex.org/W3003088935, https://openalex.org/W1967012316, https://openalex.org/W2033590167, https://openalex.org/W1583810757, https://openalex.org/W2001086065, https://openalex.org/W4250397071 |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.1158/1078-0432.24947779 |
| best_oa_location.is_oa | True |
| best_oa_location.source | |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | acceptedVersion |
| best_oa_location.raw_type | posted-content |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.1158/1078-0432.24947779 |
| primary_location.id | doi:10.1158/1078-0432.24947779 |
| primary_location.is_oa | True |
| primary_location.source | |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | acceptedVersion |
| primary_location.raw_type | posted-content |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.1158/1078-0432.24947779 |
| publication_date | 2024-01-05 |
| publication_year | 2024 |
| referenced_works_count | 0 |
| abstract_inverted_index.<p>Study | 0 |
| abstract_inverted_index.table.</p> | 2 |
| abstract_inverted_index.representativeness | 1 |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 21 |
| citation_normalized_percentile.value | 0.00352063 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |